In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)] · 2H2O, [Cu(phen)2(mal)] · 2H2O and [Mn(phen)2(mal)] · 2H2O (malH2 = malonic acid) using human cancer cells

Cancer Letters

Volumn 247, Issue 2, 2007, Pages 224-233

  Deegan, Carol ^a   McCann, Malachy ^a,b   Devereux, Michael ^a   Coyle, Barry ^b   Egan, Denise A ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

1,10 Phenanthroline; Cell carcinoma; Chemotherapeutic potential; DNA inhibition; Metal complexes

Indexed keywords

1,10 PHENANTHROLINE; CISPLATIN; COPPER DERIVATIVE; DNA; DRUG METABOLITE; MALONIC ACID DERIVATIVE; SILVER DERIVATIVE;

AMES TEST; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INTERCALATION COMPLEX; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DNA REPLICATION; HUMANS; MALONATES; METALS; MUTAGENICITY TESTS; PHENANTHROLINES;

EID: 33846995139     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.04.006     Document Type: Article

References (32)

1. Fricker P.S. Metal compounds in cancer therapy. The Role of Metals in Cancer Therapy (1994), Chapman and Hall, London 10-15
2. Marzano C., Trevisan A., Giovagnini L., and Fregonal D. Synthesis of a new platinum(II) complex: anticancer activity and nephrotoxicity in vitro. Toxicol. In Vitro 16 (2002) 413-419
3. Butler H.M., Hurse A., Thursky E., and Shulman A. Bactericidal action of selected phenanthroline chelates and related compounds. Aust. J. Expt. Biol. Med. Sci. 47 (1969) 541-552
4. MacLeod R.A. The toxicity of o-phenanthroline for lactic acid bacteria. J. Biol. Chem. 197 (1952) 751-761
5. Dwyer F.P., Reid I.K., Shulman A., Laycock G.M., and Dixon S. The biological actions of 1,10-phenanthroline and 2,2'-bipyridine hydrochlorides, quaternary salts and metal chelates and related compounds. Bacteriostatic action on selected gram-positive, gram-negative and acid-fast bacteria. Aust. J. Expt. Biol. Med. Sci. 47 (1969) 203-218
6. McCann M., Geraghty M., Devereux M., O'Shea D., Mason J., and O'Sullivan L. Insights into the mode of action of the anti-Candida activity of 1,10-phenanthroline and its metal chelates. Metal-Based Drugs 7 (2000) 185-193
7. Coyle B., McCann M., Kavanagh K., Devereux M., and Geraghty M. Mode of antifungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes. BioMetals 16 (2003) 321-329
8. Coyle B., Kinsella P., McCann M., Devereux M., O'Connor R., Clynes M., and Kavanagh K. Induction of apoptosis in yeast and mammalian cells by exposure to 1,10-phenanthroline metal complexes. Toxicol. In Vitro 18 (2004) 63-70
9. Samuni A., Chevion M., and Czapski G. Unusual copper-induced sensitisation of the biological damage due to superoxide radicals. J. Biol. Chem. 256 (1981) 12632-12635
10. Wijker C.A., and Lafleur M.V. The presence of traces of iron and copper ions during γ-irradiation does not result in clear mutational hot spots in the lacI gene. Mut. Res. 429 (1999) 27-35
11. Linder M.C. Copper and genomic stability in mammals. Mut. Res. 475 (2001) 141-152
12. Tsang S.Y., Tam S.C., Bremner L., and Burkitt M.J. Copper-1,10-phenanthroline induces internucleosomal DNA fragmentation in HepG2 cells, resulting from direct oxidation by the hydroxyl radical. Biochem. J. 317 (1996) 13-16
13. Zhou H., Lui Y., Zhen C., Gong J., Liang Y., Wang C., and Zou G. Microcalorimetric studies of the synergistic effects of copper-1,10-phenanthroline combined with hyperthermia on a liver hepatoma cell line Bel-7402. Therm. Acta 397 (2002) 87-95
14. Verhaegh G.W., Richard M.J., and Hainaut P. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down regulates p53 DNA-binding activity by increasing the intracellular levels of copper. Mol. Cell. Biol. 17 (1997) 5699-5706
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: applications to proliferation and cytotoxicity assays. J. Immunol. 65 (1983) 55-63
16. Portsmann T., Ternyck T., and Aveameas S. Quantitation of 5-bromo-2-deoxyuridine incorporation into an enzyme immunoassay for the assessment of the lymphoid proliferative response. J. Immunol. Methods 82 (1985) 169-179
17. Lorcozio A., and Long B.H. Biochemical characterisation of elasamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase II. Eur. J. Cancer 29A 14 (1993) 1985-1991
18. Moran D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity tests. Mutat. Res. 113 (1983) 173-215
19. Randford J.D., Sadler P.J., and Tocher D.A. Cytotoxicity and antiviral activity of transition-metal salicylato complexes and crystal structure of bis(diisopropylsalicylato)(1,10-phenanthroline)copper(I). Dalton Trans. (1993) 3393-3399
20. 2 = cis-5-norbornene-endo-2,3-dicarboxylic acid; bipy = 2,2′-bipyridine; phen = 1,10-phenanthroline). Polyhedron 18 (1999) 2931-2939
21. Saha D.K., Sandbhor U., Shirisha K., Padhye S., Deobagkar D., Ansond C.E., and Powell A.K. A novel mixed-ligand antimycobacterial dimeric copper complex of ciprofloxacin and phenanthroline. Bioorg. Med. Chem. Lett. 14 (2004) 3027-3032
22. Zoroddu M.A., Zanetti S., Pogni R., and Basosi R. An electron spin resonance study and antimicrobial activity of copper(II) phenanthroline complexes. J. Inorg. Biochem. 63 (1996) 291-300
23. Zhang C.X., and Lippard S.J. New metal-complexes as potential therapeutics. Curr. Opin. Chem. Biol. 7 (2003) 481-489
24. Hidalago E., and Dominguez C. Study of cytotoxic mechanisms of silver nitrate in human dermal fibroblasts. Toxicol. Lett. 98 (1997) 169-179
25. Sigman D.S., Graham D.R., D'Aurora V., and Stern A.M. Oxygen-dependent cleavage of DNA by the 1,10-phenanthroline cuprous compound. Inhibition of Escherichia coli DNA polymerase I. J. Biol. Chem. 254 (1979) 12269-12271
26. Thederahn T.B., Kumabara M.D., Larsen T.A., and Sigman D.S. Nuclease activity of 1,10-phenanthroline-copper: kinetic mechanisms. J. Am. Chem. Soc. 111 (1989) 4941-4946
27. Sigman D.S., Bruce T.W., Mazumdar A., and Sutton C.L. Targeted chemical nucleases. Acc. Chem. Res. 26 (1993) 98-104
28. Zhang S., Zhu Y., Tu C., Wei H., Yang Z., Lin L., Ding J., Zhang J., and Guo Z. A novel cationic ternary copper(II) complex of 1,10-phenanthroline and l-threonine with DNA nuclease activity. J. Inrog. Biochem. 98 (2004) 2099-2106
29. Maheswari P.U., and Palaniandavar M. DNA binding and cleavage properties of certain tetrammine ruthenium(II) complexes of modified 1,10-phenanthrolines - effect of hydrogen-bonding on DNA-binding affinity. J. Inorg. Biochem. 98 (2004) 219-230
30. Heffeter P., Jakupec M.A., Korner W., Wild S., von Keyserlingk N., Elbling L., Zorbas H., Korynevska A., Knasmuller S., Sutterluty H., Micksche M., and Keppler B.K. Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III) trithiocyanate (KP772; FFC24). Biochem. Pharm. 71 (2006) 426-440
31. Waring M.J. Variations of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation. J. Mol. Biol. 54 (1970) 247-279
32. Dougherty G. The unwinding of circular DNA by intercalating agents as determined by gel electrophoresis. Biosci. Rep. 3 (1983) 453-460